Regeneron Pharmaceuticals
REGN
#301
Rank
S$100.47 B
Marketcap
S$950.38
Share price
-0.28%
Change (1 day)
30.09%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$3.28 M-95.26%
2025S$69.45 M-20.85%
2024S$87.75 M-26.52%
2023S$0.11 B-5.6%
2022S$0.12 B-53.05%
2021S$0.26 B5.23%
2020S$0.25 B414.86%
2019S$49.73 M-31.98%
2018S$73.11 M69.52%
2017S$43.12 M-78.72%
2016S$0.20 B3.03%
2015S$0.19 B-15.29%
2014S$0.23 B419.89%
2013S$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$78.35 MS$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$0.27 BS$0.36 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$0.33 BS$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$1.71 MS$64.59 M๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$2.17 MS$56.59 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$8.14 MS$40.35 M๐Ÿ‡บ๐Ÿ‡ธ USA